跳转至内容
Merck

1.10317

Millipore

Fractogel EMD BioSEC (S)

别名:

Fractogel® EMD BioSEC (S)

登录查看公司和协议定价

选择尺寸

150 ML
$1,185.00
250 ML
$1,733.00
5000 ML
查询

$1,185.00


预计发货时间2025年7月02日详情



选择尺寸

变更视图
150 ML
$1,185.00
250 ML
$1,733.00
5000 ML
查询

About This Item

UNSPSC代码:
41115711

$1,185.00


预计发货时间2025年7月02日详情


ligand

(Modified pore structure)

质量水平

描述

for size exclusion chromatography (SEC), suspension in 20% ethanol and 150 mM NaCl (20-40 µm)

产品线

Fractogel®

参数

100 cm/hr max. flow rate
8 bar pressure

基质活性基团

Methacrylate

平均粒径

20-40 μm

转变温度

flash point 35 °C (calculated)

密度

1.43 g/cm3 at 20 °C

应用

viral therapy

分离技术

size exclusion (SEC)

储存温度

2-30°C

一般描述

Size exclusion chromatography for separation of proteins in the range between 5 kDa and 1000 kDa

特点和优势

Fractogel® EMD BioSEC (S) enables users to:

  • Effectively remove dimer and high molecular weight aggregates and complete an efficient polishing of blood plasma factors
  • Determine apparent molecular weights of proteins
  • Move predictably and efficiently from bench scale to manufacturing scale processing
  • Create a robust, consistent, and transferable process

包装

Plastic bottle

分析说明

Appearance: Milky turbid suspension,free from impurities(foreign particles)
Microscopic evaluation: Uniform sphericalparticles, noagglomerates, nofines
Extractable matter (water): ≤ 0.03 %
Cerium: ≤ 1 µg/g
Pressure drop(column: ID=1.6 cm, L=10 cm at 5 ml/min): ≤ 5.0 bar
Particle size (d10): 20 - 28 µm
Particle size (d50): 24 - 34 µm
Particle size (d90): 28 - 38 µm
Colony forming units (TAMC + TYMC): ≤ 100 CFU/ml
Endotoxins: ≤ 1.00 EU/ml
Function test (b:a): ≤ 0.7
function test (c:d): ≤ 0.05
Functional Test: Separation of bovine serum albumin, ovalbumin and cytochrom C

法律信息

FRACTOGEL is a registered trademark of Merck KGaA, Darmstadt, Germany

象形图

Flame

警示用语:

Warning

危险声明

危险分类

Flam. Liq. 3

储存分类代码

3 - Flammable liquids

WGK

WGK 3

闪点(°F)

95.0 °F

闪点(°C)

35 °C


什么是Emprove®程序?

Emprove® 程序是提供我们过滤器、一次性组件、制药原料和初始材料的全面而详尽文档的系统。

Material Qualification Dossier

免费 - 注册下载

Operational Excellence Dossier

可通过订阅或付费获得

了解更多权益。 Emprove® 程序订阅所提供的好处
为何这些文件不可用?
Emprove®档案所包含的信息旨在为药品生产商的注册和风险评估活动提供支持,其中有一些机密信息。如果您想访问这些信息,请联系我们

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

商品

A custom-designed cost model is used to explore the economics of vaccine manufacturing across several different modalities including mRNA. The model enables greater process understanding, simulates bottlenecks, and helps to optimize production efficiency.

Influenza vaccines are commonly made using egg-based and cell-based manufacturing strategies. Find step-by-step information on the manufacturing process for each method.

Learn more one the attenuated viral vaccines manufacturing process: cell culture, clarification, nuclease treatment, chromatography, and sterile filtration.

This technical article breaks down the steps of upstream and downstream bioprocessing and formulation of virus-like particle vaccines.

相关内容

This technical article breaks down the adenovirus vaccine manufacturing process and provides a case study on developing an accelerated and cost-effective single-use adenoviral vector vaccine.

Questions

Reviews

No rating value

Active Filters

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门